CN102762202A - 紫杉烷前-乳剂制剂以及制备和使用其的方法 - Google Patents
紫杉烷前-乳剂制剂以及制备和使用其的方法 Download PDFInfo
- Publication number
- CN102762202A CN102762202A CN2011800094323A CN201180009432A CN102762202A CN 102762202 A CN102762202 A CN 102762202A CN 2011800094323 A CN2011800094323 A CN 2011800094323A CN 201180009432 A CN201180009432 A CN 201180009432A CN 102762202 A CN102762202 A CN 102762202A
- Authority
- CN
- China
- Prior art keywords
- emulsion
- taxane
- preparations
- emulsion preparations
- cases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Description
成分 | 量 |
紫杉醇 | 100mg |
聚山梨醇酯80(Tween 80) | 10000mg |
丙二醇 | 2000mg |
大豆油 | 100mg |
甘露糖醇 | 10000mg |
前体乳剂的直径 | 11.7nm |
最终乳剂的直径 | 17.0nm |
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30631510P | 2010-02-19 | 2010-02-19 | |
US61/306,315 | 2010-02-19 | ||
PCT/US2011/025418 WO2011103413A2 (en) | 2010-02-19 | 2011-02-18 | Taxane pro-emulsion formulations and methods making and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102762202A true CN102762202A (zh) | 2012-10-31 |
Family
ID=44477026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011800094323A Pending CN102762202A (zh) | 2010-02-19 | 2011-02-18 | 紫杉烷前-乳剂制剂以及制备和使用其的方法 |
Country Status (9)
Country | Link |
---|---|
US (2) | US8569357B2 (zh) |
EP (1) | EP2536407A4 (zh) |
JP (1) | JP2013520435A (zh) |
KR (1) | KR20120126072A (zh) |
CN (1) | CN102762202A (zh) |
AU (1) | AU2011217951B2 (zh) |
IN (1) | IN2012DN05888A (zh) |
TW (1) | TWI438009B (zh) |
WO (1) | WO2011103413A2 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ702242A (en) * | 2012-05-31 | 2016-03-31 | Asahi Kasei Pharma Corp | Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
US11497795B2 (en) | 2018-09-28 | 2022-11-15 | Asahi Kasei Pharma Corporation | Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998030205A1 (en) * | 1997-01-07 | 1998-07-16 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
WO2000050007A1 (en) * | 1999-02-26 | 2000-08-31 | Lipocine, Inc. | Compositions and methods for improved delivery of hydrophobic therapeutic agents |
US20030099674A1 (en) * | 2001-08-11 | 2003-05-29 | Chen Andrew X. | Lyophilized injectable formulations containing paclitaxel or other taxoid drugs |
US20060078618A1 (en) * | 2001-12-11 | 2006-04-13 | Constantinides Panayiotis P | Lipid particles and suspensions and uses thereof |
CN1823737A (zh) * | 1999-05-27 | 2006-08-30 | 阿库斯菲尔公司 | 多孔药物基质及其制造方法 |
WO2007082978A1 (es) * | 2006-01-20 | 2007-07-26 | Eriochem S.A. | Una formulación farmacéutica de taxano, una composición sólida de taxano, un procedimiento para la preparación de dicha composición sólida de taxano, una composición solubilizante de dicha composición sólida de taxano, y un conjunto de elementos (kit) par |
CN101094646A (zh) * | 2004-09-28 | 2007-12-26 | 陈献 | 用于输送紫杉烷及其它不溶性药物的低油乳剂组合物 |
WO2008105852A2 (en) * | 2006-10-26 | 2008-09-04 | Creighton University | Mucoadhesive nanoparticles for cancer treatment |
CN101428002A (zh) * | 2008-11-20 | 2009-05-13 | 沈阳万爱普利德医药科技有限公司 | 注射用紫杉醇冻干微乳剂及其制备方法 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5407683A (en) * | 1990-06-01 | 1995-04-18 | Research Corporation Technologies, Inc. | Pharmaceutical solutions and emulsions containing taxol |
US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
US5698582A (en) * | 1991-07-08 | 1997-12-16 | Rhone-Poulenc Rorer S.A. | Compositions containing taxane derivatives |
FR2678833B1 (fr) * | 1991-07-08 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes. |
US5750561A (en) * | 1991-07-08 | 1998-05-12 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
DE4208527A1 (de) * | 1992-03-17 | 1993-09-23 | Max Planck Gesellschaft | Liposomen mit negativer ueberschussladung |
US5602112A (en) * | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
ES2224200T3 (es) * | 1992-11-27 | 2005-03-01 | Mayne Pharma (Usa) Inc. | Composicion inyectable estable de paclitaxel. |
FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US6753006B1 (en) * | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
US6537579B1 (en) * | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
US6096331A (en) * | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US6749868B1 (en) * | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
BR9405798A (pt) * | 1993-02-22 | 1995-12-12 | Vivorx Pharmaceuticals Inc | Métodos para liberação in vivo de material biológico e composições úteis dos mesmos |
US5785976A (en) * | 1993-03-05 | 1998-07-28 | Pharmacia & Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
US5885486A (en) * | 1993-03-05 | 1999-03-23 | Pharmaciaand Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
US5415869A (en) * | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
US5925669A (en) * | 1994-03-22 | 1999-07-20 | Molecular/Structural Bio Technologies, Inc. | Carrier compositions for anti-neoplastic drugs |
US5616330A (en) * | 1994-07-19 | 1997-04-01 | Hemagen/Pfc | Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
DE4430593C2 (de) * | 1994-08-20 | 1999-01-14 | Max Delbrueck Centrum | Verfahren zur Herstellung von Liposomal verkapseltem Taxol |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
US5789000A (en) * | 1994-11-14 | 1998-08-04 | Bionumerik Pharmaceuticals, Inc. | Sterile aqueous parenteral formulations of cis-diammine dichloro platinum |
US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
EP0760237A1 (en) * | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
KR100330373B1 (ko) * | 1996-05-28 | 2002-11-07 | 주식회사한국신약 | 탁솔을 함유한 주사용 약제 조성물 |
US5877205A (en) * | 1996-06-28 | 1999-03-02 | Board Of Regents, The University Of Texas System | Parenteral paclitaxel in a stable non-toxic formulation |
US6727280B2 (en) * | 1997-01-07 | 2004-04-27 | Sonus Pharmaceuticals, Inc. | Method for treating colorectal carcinoma using a taxane/tocopherol formulation |
US6121245A (en) * | 1997-01-29 | 2000-09-19 | Firshein; Richard N. | Method of treating cancer using alkylglycerols in conjunction with chemotherapy |
US6531139B1 (en) * | 1997-07-29 | 2003-03-11 | Pharmacia & Upjohn Company | Self-emulsifying formulation for lipophilic compounds |
US6281175B1 (en) * | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
US6090407A (en) * | 1997-09-23 | 2000-07-18 | Research Development Foundation | Small particle liposome aerosols for delivery of anti-cancer drugs |
AU2845599A (en) * | 1998-03-05 | 1999-09-20 | Phares Pharmaceutical Research N.V. | Pharmaceutical compositions and their use |
US6979456B1 (en) * | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
KR20010052368A (ko) * | 1998-05-20 | 2001-06-25 | 질레스피 카롤 | 신규한 입자 제형 |
US7030155B2 (en) * | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US6071952A (en) * | 1998-12-02 | 2000-06-06 | Mylan Pharmaceuticals, Inc. | Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
US6537585B1 (en) * | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
WO2000071163A1 (en) * | 1999-05-24 | 2000-11-30 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US6610317B2 (en) * | 1999-05-27 | 2003-08-26 | Acusphere, Inc. | Porous paclitaxel matrices and methods of manufacture thereof |
US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
TW422706B (en) * | 1999-07-01 | 2001-02-21 | Wang Iz Rung | An oil-in-water emulsion type of paclitaxel |
US6348215B1 (en) * | 1999-10-06 | 2002-02-19 | The Research Foundation Of State University Of New York | Stabilization of taxane-containing dispersed systems |
US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
JP2003521545A (ja) * | 2000-02-02 | 2003-07-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 改良された溶解性を有するタキサン製剤 |
JP3448006B2 (ja) * | 2000-03-29 | 2003-09-16 | 独立行政法人食品総合研究所 | 機能性エマルション |
US6761901B1 (en) * | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
DE10036871A1 (de) * | 2000-07-28 | 2002-02-14 | Pharmasol Gmbh | Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe |
AU2003265511A1 (en) * | 2002-08-21 | 2004-03-11 | Pharmacia Corporation | Injectable pharmaceutical suspension in a two-chamber vial |
US7345093B2 (en) * | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
WO2010018596A2 (en) * | 2008-07-23 | 2010-02-18 | Bharat Serums And Vaccines Ltd. | Stable injectable oil-in-water docetaxel nanoemulsion |
-
2011
- 2011-02-17 TW TW100105178A patent/TWI438009B/zh not_active IP Right Cessation
- 2011-02-18 KR KR1020127018554A patent/KR20120126072A/ko not_active Application Discontinuation
- 2011-02-18 IN IN5888DEN2012 patent/IN2012DN05888A/en unknown
- 2011-02-18 US US13/030,495 patent/US8569357B2/en active Active
- 2011-02-18 EP EP11745314.2A patent/EP2536407A4/en not_active Withdrawn
- 2011-02-18 CN CN2011800094323A patent/CN102762202A/zh active Pending
- 2011-02-18 JP JP2012554053A patent/JP2013520435A/ja active Pending
- 2011-02-18 WO PCT/US2011/025418 patent/WO2011103413A2/en active Application Filing
- 2011-02-18 AU AU2011217951A patent/AU2011217951B2/en active Active
-
2013
- 2013-09-12 US US14/025,695 patent/US20140088181A1/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998030205A1 (en) * | 1997-01-07 | 1998-07-16 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
WO2000050007A1 (en) * | 1999-02-26 | 2000-08-31 | Lipocine, Inc. | Compositions and methods for improved delivery of hydrophobic therapeutic agents |
CN1823737A (zh) * | 1999-05-27 | 2006-08-30 | 阿库斯菲尔公司 | 多孔药物基质及其制造方法 |
US20030099674A1 (en) * | 2001-08-11 | 2003-05-29 | Chen Andrew X. | Lyophilized injectable formulations containing paclitaxel or other taxoid drugs |
US20060078618A1 (en) * | 2001-12-11 | 2006-04-13 | Constantinides Panayiotis P | Lipid particles and suspensions and uses thereof |
CN101094646A (zh) * | 2004-09-28 | 2007-12-26 | 陈献 | 用于输送紫杉烷及其它不溶性药物的低油乳剂组合物 |
WO2007082978A1 (es) * | 2006-01-20 | 2007-07-26 | Eriochem S.A. | Una formulación farmacéutica de taxano, una composición sólida de taxano, un procedimiento para la preparación de dicha composición sólida de taxano, una composición solubilizante de dicha composición sólida de taxano, y un conjunto de elementos (kit) par |
WO2008105852A2 (en) * | 2006-10-26 | 2008-09-04 | Creighton University | Mucoadhesive nanoparticles for cancer treatment |
WO2008105852A3 (en) * | 2006-10-26 | 2008-11-06 | Univ Creighton | Mucoadhesive nanoparticles for cancer treatment |
CN101428002A (zh) * | 2008-11-20 | 2009-05-13 | 沈阳万爱普利德医药科技有限公司 | 注射用紫杉醇冻干微乳剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2536407A2 (en) | 2012-12-26 |
TWI438009B (zh) | 2014-05-21 |
TW201141538A (en) | 2011-12-01 |
IN2012DN05888A (zh) | 2015-09-18 |
AU2011217951B2 (en) | 2013-07-11 |
KR20120126072A (ko) | 2012-11-20 |
US20140088181A1 (en) | 2014-03-27 |
AU2011217951A1 (en) | 2012-07-19 |
WO2011103413A2 (en) | 2011-08-25 |
US20110207803A1 (en) | 2011-08-25 |
JP2013520435A (ja) | 2013-06-06 |
WO2011103413A3 (en) | 2012-01-12 |
US8569357B2 (en) | 2013-10-29 |
EP2536407A4 (en) | 2013-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kan et al. | A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect | |
KR101752944B1 (ko) | 비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법 | |
KR101505419B1 (ko) | 나노분산액 | |
NZ586859A (en) | Drug delivery system for administration of poorly water soluble pharmaceutically active substances | |
US9308195B2 (en) | Non-aqueous taxane formulations and methods of using the same | |
KR20180006902A (ko) | 카바지탁셀 지방 에멀젼 주사제 및 이를 제조하는 방법 및 그의 사용 | |
CN102762202A (zh) | 紫杉烷前-乳剂制剂以及制备和使用其的方法 | |
EA016619B1 (ru) | Новые композиции на основе таксоидов | |
CA2732901A1 (en) | Injectable taxane pharmaceutical composition | |
US20070032438A1 (en) | Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions | |
SI21138A (sl) | Stabilna farmacevtska oblika zdravila proti raku | |
CN104323990B (zh) | 一种紫杉烷衍生物tm‑2的脂质微球注射液及其制备方法 | |
UA96273C2 (uk) | Композиція доцетакселу і цитрату для лікування раку | |
CZ465599A3 (cs) | Způsoby potenciace intravenosního estramustinfosfátu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: TECHNO GUARD CO., LTD. Effective date: 20121205 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20121205 Address after: American California Applicant after: Teikoku Pharma USA, Inc. Address before: American California Applicant before: Teikoku Pharma USA, Inc. Applicant before: Techno Guard Co., Ltd. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1174850 Country of ref document: HK |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121031 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1174850 Country of ref document: HK |